Increased levels of circulating endothelial progenitor cells and circulating endothelial nitric oxide synthase in patients with gliomas

Annals of Neurology

Volumn 62, Issue 1, 2007, Pages 40-48

  Zheng, Ping Pin ^a   Hop, Wim C ^a   Luider, Theodorus M ^a   Sillevis Smitt, Peter A E ^a   Kros, Johan M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; ENDOGLIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD133; MONOCLONAL ANTIBODY CD34; MONOCLONAL ANTIBODY KDR; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ADOLESCENT; ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD SAMPLING; CENTRAL NERVOUS SYSTEM TUMOR; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME BLOOD LEVEL; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GLIOMA; HUMAN; HUMAN TISSUE; MALE; NETHERLANDS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STEM CELL; STROKE;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ENDOTHELIAL CELLS; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; STATISTICS, NONPARAMETRIC; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 34547817054     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21151     Document Type: Article

References (53)

1. Tuettenberg J, Friedel C, Vajkoczy P. Angiogenesis in malignant glioma - a target for antitumor therapy? Crit Rev Oncol Hematol 2006;59:181-193.
2. Fischer I, Gagner JP, Law M, et al. Angiogenesis in gliomas: biology and molecular pathophysiology. Brain Pathol 2005;15: 297-310.
3. Holash J, Maisonpierre PC, Compton D, et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999;284:1994-1998.
4. Moore XL, Lu J, Sun L, et al. Endothelial progenitor cells' "homing" specificity to brain tumors. Gene Ther 2004;11: 811-818.
5. Yue WY, Chen ZP. Does vasculogenic mimicry exist in astrocytoma? J Histochem Cytochem 2005;53:997-1002.
6. Cohen MM Jr. Vascular update: morphogenesis, tumors, malformations, and molecular dimensions. Am J Med Genet A 2006;140:2013-2038.
7. Hristov M, Weber C. Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med 2004;8:498-508.
8. Zammaretti P, Zisch AH. Adult 'endothelial progenitor cells'. Renewing vasculature. Int J Biochem Cell Biol 2005;37: 493-503.
9. Goon PK, Boos CJ, Stonelake PS, Lip GY. Circulating endothelial cells in malignant disease. Fut Oncol 2005;1:813-820.
10. Ingram DA, Caplice NM, Yoder MC. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 2005;106:1525-1531.
11. Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000;95: 952-958.
12. Asahara T, Kawamoto A. Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol 2004;287: C572-579.
13. Bompais H, Chagraoui J, Canron X, et al. Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells. Blood 2004;103:2577-2584.
14. Blann AD, Woywodt A, Bertolini F, et al. Circulating endothelial cells. Biomarker of vascular disease. Thromb Haemost 2005;93:228-235.
15. Elshal MF, Khan SS, Takahashi Y, et al. CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood. Blood 2005;106:2923-2924.
16. Shaffer RG, Greene S, Arshi A, et al. Flow cytometric measurement of circulating endothelial cells: The effect of age and peripheral arterial disease on baseline levels of mature and progenitor populations. Cytometry B Clin Cytom 2006;70:56-62.
17. Mancuso P, Burlini A, Pruneri G, et al. Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 2001;97:3658-3661.
18. Schlingemann RO, Rietveld FJ, de Waal RM, et al. Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma. Lab Invest 1990;62:690-696.
19. Wang JM, Kumar S, Pye D, et al. A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues. Int J Cancer 1993;54:363-370.
20. Miller DW, Graulich W, Karges B, et al. Elevated expression of endoglin, a component of the TGF-beta-receptor complex, correlates with proliferation of tumor endothelial cells. Int J Cancer 1999;81:568-572.
21. Yu JX, Cui L, Zhang QY, et al. Expression of NOS and HIF-1alpha in human colorectal carcinoma and implication in tumor angiogenesis. World J Gastroenterol 2006;12:4660-4664.
22. Pierelli L, Scambia G, Bonanno G, et al. CD34+/CD105+ cells are enriched in primitive circulating progenitors residing in the G0 phase of the cell cycle and contain all bone marrow and cord blood CD34+/CD38low/- precursors. Br J Haematol 2000;108:610-620.
23. Pierelli L, Bonanno G, Rutella S, et al. CD105 (endoglin) expression on hematopoietic stem/progenitor cells. Leuk Lymphoma 2001;42:1195-1206.
24. Fish JE, Marsden PA. Endothelial nitric oxide synthase: insight into cell-specific gene regulation in the vascular endothelium. Cell Mol Life Sci 2006;63:144-162.
25. Duda DG, Fukumura D, Jain RK. Role of eNOS in neovascularization: NO for endothelial progenitor cells. Trends Mol Med 2004;10:143-145.
26. Hood JD, Meininger CJ, Ziche M, Granger HJ. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol 1998;274:H1054-H1058.
27. Munaut C, Noel A, Hougrand O, et al. Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas. Int J Cancer 2003;106:848-855.
28. Metzger IF, Souza-Costa DC, Marroni AS, et al. Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men. Pharmacogenet Genomics 2005;15:565-570.
29. Li R, Lyn D, Lapu-Bula R, et al. Relation of endothelial nitric oxide synthase gene to plasma nitric oxide level, endothelial function, and blood pressure in African Americans. Am J Hypertens 2004;17:560-567.
30. Storms RW, Green PD, Safford KM, et al. Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34. Blood 2005;106: 95-102.
31. Sutherland DR, Keating A, Nayar R, et al. Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. Exp Hematol 1994;22:1003-1010.
32. Hur J, Yoon CH, Kim HS, et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004;24: 288-293.
33. Lewis Carl SA, Gillete-Ferguson I, Ferguson DG. An indirect immunofluorescence procedure for staining the same cryosection with two mouse monoclonal primary antibodies. J Histochem Cytochem 1993;41:1273-1278.
34. Zheng PP, van der Weiden M, Kros JM. Differential expression of Hela-type caldesmon in tumour neovascularization: a new marker of angiogenic endothelial cells. J Pathol 2005;205: 408-414.
35. Ho JW, Pang RW, Lau C, et al. Significance of circulating endothelial progenitor cells in hepatocellular carcinoma. Hepatology 2006;44:836-843.
36. Raida M, Weiss T, Leo C, et al. Circulating endothelial progenitor cells are inversely correlated with the median oxygen tension in the tumor tissue of patients with cervical cancer. Oncol Rep 2006;16:597-601.
37. Dome B, Timar J, Dobos J, et al. Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. Cancer Res 2006;66:7341-7347.
38. Furstenberger G, von Moos R, Lucas R, et al. Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer. Br J Cancer 2006;94: 524-531.
39. Wierzbowska A, Robak T, Krawczynska A, et al. Circulating endothelial cells in patients with acute myeloid leukemia. Eur J Haematol 2005;75:492-497.
40. Zhang H, Vakil V, Braunstein M, et al. Circulating endothelial progenitor cells in multiple myeloma: implications and significance. Blood 2005;105:3286-3294.
41. Ingram DA, Mead LE, Moore DB, et al. Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 2005;105: 2783-2786.
42. Komarova NL, Mironov V. On the role of endothelial progenitor cells in tumor neovascularization. J Theor Biol 2005;235: 338-349.
43. Iwata S, Nakagawa K, Harada H, et al. Endothelial nitric oxide synthase expression in tumor vasculature is correlated with malignancy in human supratentorial astrocytic tumors. Neurosurgery 1999;45:24-29.
44. Pan JW, Zhan RY, Tong Y, et al. Expression of endothelial nittic oxide synthase and vascular endothelial growth factor in association with neovascularization in human primary astrocytoma. J Zhejiang Univ Sci B 2005;6:693-698.
45. Hoetzer GL, Irmiger HM, Keith RS, et al. Endothelial nitric oxide synthase inhibition does not alter endothelial progenitor cell colony forming capacity or migratory activity. J Cardiovasc Pharmacol 2005;46:387-389.
46. Shirota T, He H, Yasui H, Matsuda T. Human endothelial progenitor cell-seeded hybrid graft: proliferative and antithrombogenic potentials in vitro and fabrication processing. Tissue Eng 2003;9:127-136.
47. Hristov M, Erl W, Weber PC. Endothelial progenitor cells: isolation and characterization. Trends Cardiovasc Med 2003;13: 201-206.
48. Jerkic M, Rivas-Elena JV, Prieto M, et al. Endoglin regulates nitric oxide-dependent vasodilatation. Faseb J 2004;18:609-611.
49. Li DY, Sorensen LK, Brooke BS, et al. Defective angiogenesis in mice lacking endoglin. Science 1999;284:1534-1537.
50. Fonsatti E, Maio M. Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer. J Transl Med 2004;2:18.
51. Goon PK, Lip GY, Boos CJ, et al. Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer. Neoplasia 2006;8:79-88.
52. Venditti A, Battaglia A, Del Poeta G, et al. Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods. Bone Marrow Transplant 1999;24:1019-1027.
53. Massa M, Rosti V, Ramajoli I, et al. Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia. J Clin Oncol 2005;23:5688-5695.